Opthea’s Post

A series of top #NewsReleases over the course of the last 14 days woke up some earlybirds & #SmartInvestors which led to a weekly #breakout (please see chart below) for Avicanna Inc. (TSX:AVCN) shares of its downtrend since Sept 2023. Next resistance would be a weekly close above 0,50 CAD which would offer a quick upside potential of another 60 % to reach the 0,80 CAD mark. As an #investor in #people and #megatrends we realized the potential of this #pearl in the #biopharma sector early and used the bottom building sideway range since early 2022 for building a strategic position. This sideway range is going to be broken out to the upside which will lead to substantial MCAP and price appreciation. Check out the news release today and just add 1+1 what it means for the the future growth and financial numbers for this SmallCap company. https://lnkd.in/dCYswRet #InvestmentCase #FamilyOffices #CommercialStage #VerticallyIntegrated and #Diversified #Biopharma #PlatformCompany

IW Capital is proud to have completed a further investment in Flarin Holdings Ltd to support the rapid expansion of Flarin® , the lipid formulation ibuprofen which is now one of the fastest growing analgesics in the UK. Alongside us, we have been joined by ITV AdVentures who provided a Media for Equity investment of up to £5 million in the form of advertising inventory across all of ITV's channels. This is ITV's first consumer healthcare investment. Flarin® is a patent-protected anti-inflammatory painkiller which is clinically proven to be as effective as twice the dose of standard ibuprofen in patients with acute joint and muscular pain.    IW's latest investment of £1.8 million alongside ITV, will allow  Flarin® to continue its strong growth in becoming a major oral joint and muscular pain relief brand in the UK. Alan Armstrong, Head of Investment at IW Capital, said: “We are delighted to continue to support the management team to grow and develop the business with our further investment. It is exciting to welcome ITVAdVentures as an investor and partner. By raising consumer awareness of Flarin® across ITV’s platforms, we are confident that Flarin® will become a major oral joint and muscular pain relief brand in the UK “   Flarin® showcases our investment ethos of Investing Well in businesses that are focused on improving people’s lives.    #IWCapital #BusinessGrowth #InvestWell #Healthcare  

The latest edition of Navagant newsletter is out, featuring transactions from Instructure, Teaching Strategies, LLC, KKR, Intelvio (formerly Phlebotomy Training Specialists), Shutterstock, Kids Planet Day Nurseries, and more! Please reach out to learn more about any of these transactions or talk to a Navagant representative about the Education & Training M&A market! #educationandtraining #mergersandacquisitions #investmentbanking #learninganddevelopment #corporatetraining https://lnkd.in/e42BVUDN

This is a very interesting combination and seems like a better way for the west coast guys to enter FL, especially with valuations so low. Vidcann has great quality and is the best distillates in the market (flower is top three right now too). Their grow can accommodate a doubling of the combined entity footprint, they get a public entity for growth when the capital market open back up and Planet 13 gets some badly needed diversity. Planet 13 is far more geared for the coming AU market as well so a ton to like about this. And taking 26% of the combined entity NOW is a prudent exit without leaving the upside on the table for Vidacann.

Why does EOS work? It is based on two main ideas: clarify and simplify! This gets everyone on the same page rowing in the same direction!

The partnership between Star Strong Capital and Naboso Technology, Inc is a story of shared goals and mutual growth. Dr. Splichal's vision at Naboso, focusing on foot stimulation for improved health, is breaking new ground in the wellness industry. SSC's timely support played a crucial role in scaling this innovation and breaking into new markets. What a number to prove it - Naboso has achieved a 65% YoY growth. Their success speaks volumes about our common commitment to wellness innovation and the impact of Naboso's products. As Naboso moves closer to gaining FDA approval, their journey just gets more exhilarating. Kudos to both parties for this fruitful collaboration!👏' The story goes back to when a creative agency called Digital Surgeons introduced Naboso and SSC. When Naboso was all set to roll with an energetic marketing campaign and innovative products, SSC stepped in at the right time and provided the necessary funding. SSC's support helped Naboso to scale up its operations and venture into new markets. Both SSC and Naboso saw the transformative potential of foot stimulation for improving quality of life, and they anticipated the revolution in wellness that Naboso's products could bring about. The shared vision could be paying off. To learn about the SSC-Naboso relationship, check out our latest article below. https://bit.ly/4dme29h #wellnessinvesting #wellnessbusiness #wellnessindustry #naboso

Look who I ran into on day 1 of #Succeet, J.R. Venza, PRC! We keep missing each other around metro Atlanta but here we are in Wiesbaden, Germany! #marketresearch #Succeet #datacollection #marketxcel #Torfac #quantqual #Online #Offline

The Alliance for Parking Data Standards will be at Parkex! Join the session that will be moderated by Nigel Williams, President of the European Parking Association, at the main stage on Wednesday May 22nd at 11:30am where specialist speakers will be showcasing live use cases of APDS in the industry. The APDS mission is to develop, promote, manage, and maintain a uniform global standard that will allow organizations to share parking data across platforms worldwide. Don't miss your chance to get answers to your burning APDS questions! #APDS #ParkingData #Parking #DataStandards

Really excited to see friends, old and new, and get on board with what's new in market research at Succeet23. As always #JTN brings our A-team, this time to Wiesbaden. Looking forward to talk to all of you there #succeet23 #mrx #marketresearch #consumerresearch